Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01634828 · ClinicalTrials.gov registry record
Method for Improved Intraoperative Blood Loss Estimates
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 47
- Enrollment target
NCT01634828: Completed study, sponsored by University of Utah.
NCT01634828 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 47 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01634828 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to develop a mathematical algorithm which the investigators plan to use to more accurately estimate intraoperative blood loss.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2012-07 |
| Est. Completion | 2015-04 |
What the finished NCT01634828 record still lists
NCT01634828 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 47 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01634828 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01634828 about?
NCT01634828 is a clinical study titled "Method for Improved Intraoperative Blood Loss Estimates". The purpose of this study is to develop a mathematical algorithm which the investigators plan to use to more accurately estimate intraoperative blood loss.
What is the current status of trial NCT01634828?
This trial is currently completed. The enrollment target is 47 participants. The study started on 2012-07. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01634828?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03313011 · 47 participants
The Neurobiology of Two Distinct Types of Progressive Apraxia of Speech
- NCT03467516 · 47 participants · Phase 2
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Metastatic Uveal Melanoma
- NCT03886662 · 47 participants · Phase 1
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- NCT04013802 · 47 participants · Phase 1
TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia